Blincyto, the first and only FDA-approved Bispecific CD19-directed CD3 T-cell Engager
On March 30th, 2015
- Speaker: Dr. Stefan Faderl, chief Leukemia Division of Hackensack Medical Center in New Jersey
- 6pm, April 1, 2015
- Mahogany, 3241 West Memorial Road, OKC (405-748-5859)
- RSVPs can be sent to Ruth Kostur at 503-412-9999 or rkostur@onyx.com.
- Click Here for more information
- Speaker: Dr. Stefan Faderl, chief Leukemia Division of Hackensack Medical Center in New Jersey
- 6pm, April 1, 2015
- Mahogany, 3241 West Memorial Road, OKC (405-748-5859)
- RSVPs can be sent to Ruth Kostur at 503-412-9999 or rkostur@onyx.com.
- Click Here for more information
No comments have been posted yet.